Related references
Note: Only part of the references are listed.Molecular Aspects of Thyroid Hormone Actions
Sheue-Yann Cheng et al.
ENDOCRINE REVIEWS (2010)
Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by Thyroid Hormone ROLE OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ COACTIVATOR (PGC-1α)
Ramy R. Attia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist
Barry G. Shearer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Novel Flufenamic Acid Analogues as Inhibitors of Androgen Receptor Mediated Transcription
Clementine Feau et al.
ACS CHEMICAL BIOLOGY (2009)
In Vivo Interaction of Steroid Receptor Coactivator (SRC)-1 and the Activation Function-2 Domain of the Thyroid Hormone Receptor (TR) β in TRβ E457A Knock-In and SRC-1 Knockout mice
Manuela Alonso et al.
ENDOCRINOLOGY (2009)
Improvement of Pharmacological Properties of Irreversible Thyroid Receptor Coactivator Binding Inhibitors
Jong Yeon Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Thyroid hormones and the control of cell proliferation or cell differentiation: Paradox or duality?
Elsa Kress et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
A High-Throughput Ligand Competition Binding Assay for the Androgen Receptor and Other Nuclear Receptors
Clementine Feau et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Nuclear receptor drug discovery
Taosheng Chen
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor
Douglas J. Kojetin et al.
ENDOCRINE-RELATED CANCER (2008)
Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor γ to PGC-1α
Yong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Blocking Estrogen Signaling After the Hormone: Pyrimidine-Core Inhibitors of Estrogen Receptor-Coactivator Binding
Alexander A. Parent et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against β-lactamase
Kerim Babaoglu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Ligand induced interaction of thyroid hormone receptor beta with its coregulators
Napoleau F. Valadares et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines
Vanya Shah et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Access and binding of local anesthetics in the closed sodium channel
Iva Bruhova et al.
MOLECULAR PHARMACOLOGY (2008)
Structural insight into the mode of action of a direct inhibitor of coregulator binding to the thyroid hormone receptor
Eva Estebanez-Perpina et al.
MOLECULAR ENDOCRINOLOGY (2007)
Inhibitors of the interaction of a thyroid hormone receptor and coactivators:: Preliminary structure-activity relationships
Leggy A. Arnold et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Assay optimization and screening of RNA-protein interactions by AlphaScreen
Nicholas L. Mills et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
β-aminoketones as prodrugs with pH-controlled activation
Ana Luisa Simplicio et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Activated pregnenolone X-receptor is a target for ketoconazole and its analogs
Hongwei Wang et al.
CLINICAL CANCER RESEARCH (2007)
SRC-p300 coactivator complex is required for thyroid hormone-induced amphibian metamorphosis
Bindu D. Paul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole
H. Huang et al.
ONCOGENE (2007)
Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer
VC Jordan
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Medicinal chemistry of hERG optimizations: Highlights and hang-ups
Craig Jamieson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor β
Yong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The nuclear receptor superfamily and drug discovery
John T. Moore et al.
CHEMMEDCHEM (2006)
Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators
LA Arnold et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release
S Kansra et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
The nuclear receptor superfamily:: A personal retrospect on the first two decades
P Chambon
MOLECULAR ENDOCRINOLOGY (2005)
A new amino-masking group capable of pH-triggered amino-drug release
JF Gilmer et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide
JL Vanhooke et al.
BIOCHEMISTRY (2004)
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates:: Selective actions relative to 3,5,3′-triiodo-L-thyronine
GJ Grover et al.
ENDOCRINOLOGY (2004)
The coactivator LXXLL nuclear receptor recognition motif
RS Savkur et al.
JOURNAL OF PEPTIDE RESEARCH (2004)
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor a coactivator binding
AL Rodriguez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Quantitative proteomics of the thyroid hormone receptor-coregulator interactions
JMR Moore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Evidence for a potent antiinflammatory effect of rosiglitazone
P Mohanty et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Principles for modulation of the nuclear receptor superfamily
H Gronemeyer et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Review of the in vivo functions of the p160 steroid receptor coactivator family
JM Xu et al.
MOLECULAR ENDOCRINOLOGY (2003)
Development of a versatile platform for nuclear receptor screening using AlphaScreen™
N Rouleau et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
Design of thyroid hormone receptor antagonists from first principles
P Webb et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
A thyroid hormone antagonist that inhibits thyroid hormone action in vivo
W Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Studies on the toxicity and efficacy of some ester analogues of dapsone in vitro using rat and human tissues
MD Coleman et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2002)
Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment
NH Nguyen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Mechanism of thyroid hormone action
CB Harvey et al.
THYROID (2002)
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662
LM Leesnitzer et al.
BIOCHEMISTRY (2002)
A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors
JF Glickman et al.
JOURNAL OF BIOMOLECULAR SCREENING (2002)
Inhalation toxicity studies of the α,β-unsaturated ketones:: Ethyl vinyl ketone
DL Morgan et al.
INHALATION TOXICOLOGY (2001)
Nitrobenzene compounds inhibit expression of VCAM-1
CQ Meng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Cloning and characterization of two novel thyroid hormone receptor β isoforms
GR Williams
MOLECULAR AND CELLULAR BIOLOGY (2000)
Asymmetry in the PPAR gamma/RXR alpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors
RT Gampe et al.
MOLECULAR CELL (2000)
Share Paper
